MORGAN STANLEY - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,503
-41.6%
23,347
-1.3%
0.00%
Q3 2022$6,000
-62.5%
23,647
-43.8%
0.00%
Q2 2022$16,000
-44.8%
42,109
-6.2%
0.00%
Q1 2022$29,000
-77.9%
44,876
-64.8%
0.00%
Q4 2021$131,000
-51.7%
127,664
-34.4%
0.00%
Q3 2021$271,000
-62.0%
194,618
-4.2%
0.00%
Q2 2021$713,000
+176.4%
203,075
+438.6%
0.00%
Q1 2021$258,00037,7030.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders